17-Year-Old in Upper Bavaria Battles Mysterious Illness

A 17-year-old girl from Huglfing, Upper Bavaria, is living in near-total isolation due to a severe neuroimmunological condition known as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Since October 2025, the teenager, identified as Melina, has remained confined to her bed in a darkened room to manage the extreme symptoms of the disease.

According to reporting from Merkur, Melina’s condition began following an infection. The disease has left her hypersensitive to external stimuli, where even small triggers such as sunlight or the sound of people walking nearby cause significant stress to her body.

To mitigate these reactions, Melina remains in a room with the shutters closed and uses a fabric mask to cover her eyes. This environment is necessary to protect her from light and noise, which otherwise worsen her state.

Impact on Family and Daily Life

The severity of the illness has placed a profound emotional and physical strain on Melina’s parents, Björn and Birgit Oberhauser. The family describes their current situation as being very much at the limit.

Because of the constant care required, the family is unable to engage in normal activities or outings. Björn Oberhauser noted that one person must always be here to support their daughter.

The home has become a site of intensive medical management. Björn Oberhauser stated that if you see all the medicine we have here, you would think It’s a testing laboratory.

Understanding ME/CFS

ME/CFS is characterized as a diagnosis of exclusion, meaning it is often identified after other potential causes for the symptoms have been ruled out. The disease manifests through a complex array of symptoms that affect multiple bodily systems.

The Deutsche Gesellschaft für ME/CFS provides a clinical definition of the condition:

ME/CFS is a severe neuroimmunological disease that often leads to a high degree of physical disability.

Deutsche Gesellschaft für ME/CFS

Patients suffering from this condition typically experience:

• Severe physical weakness
• Neurocognitive impairments
• Autonomic nervous system dysfunction
• Immunological symptoms

Prevalence and Treatment Challenges

The scale of the disease is significant, though it often remains under-recognized. Data from the Deutsche Gesellschaft für ME/CFS indicates that approximately 40 million people worldwide are affected by the condition, with roughly 650,000 cases in Germany alone.

Despite the number of affected individuals, the disease remains poorly researched. There are currently no effective medications to cure ME/CFS, leaving patients and families to rely heavily on pain management.

For Melina, the primary medical intervention has been the repeated use of painkillers to manage the chronic pain that plagues her daily existence.